Table 5.
Risk factors for CMV.
| Risk factors | CMV | P value∗ | ||
|---|---|---|---|---|
| No (n = 93) | Yes (n = 4) | |||
| Age/years | Mean (SD) | 8.69 (6.01) | 13.63 (4.21) | 0.03 |
| Median (range) | 10 (1–21) | 15 (6.5–18) | ||
|
| ||||
| Gender | Females | 32 (34.41%) | 3 (75.00%) | 0.14 |
| Males | 61 (65.59%) | 1 (25.00%) | ||
|
| ||||
| Duration of the disease/years | Mean (SD) | 7.82 (4.92) | 13.69 (3.79) | 0.03 |
|
| ||||
| Frequency of blood transfusion/months | Mean (SD) | 1.09 (0.43) | 0.88 (0.25) | 0.21 |
|
| ||||
| Splenectomy | No | 55 (59.14%) | 1 (25.00%) | 0.31 |
| Yes | 38 (40.86%) | 3 (75.00%) | ||
|
| ||||
| Ferritin level (ng/dL) | Mean (SD) | 2894 (1770) | 4735 (1789) | 0.04 |
|
| ||||
| Alanine transaminase (ALT) (U/L) | Mean (SD) | 55 (3.4) | 56 (3.7) | 0.43 |
|
| ||||
| Aspartate aminotransferase (AST) (U/L) | Mean (SD) | 50 (6.44) | 54 (6.8) | 0.14 |
∗ P values were obtained by using Mann-Whitney test, Chi-square test, or Fisher exact test.